Results for tag: "Caspase 3"

Caspase 3 is a protease enzyme that plays a key role in apoptosis, or programmed cell death, in the body. It is a target for oncology drugs, as it is involved in the development and progression of many types of cancer. Inhibiting caspase 3 can help to reduce the growth of cancer cells, and can also help to reduce the side effects of chemotherapy. In the oncology drug market, caspase 3 inhibitors are used to treat a variety of cancers, including breast, lung, and colorectal cancer. These drugs are typically administered in combination with other treatments, such as chemotherapy or radiation therapy. Several companies are involved in the development and marketing of caspase 3 inhibitors. These include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more